Skip Menu
faculty photo
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
Sean D. Sullivan
Professor
Professor, Department of Pharmacy (primary appt.)
Adjunct Professor, Allergy and Infectious Dis.

Sean D. Sullivan, BScPharm, MSc, PhD, is Professor and Associate Dean for Research at the University of Washington School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health, is Director of the UW Pharmaceutical Outcomes Research and Policy Program (PORPP) and co-Director of the University of Washington Centers for Comparative and Health Systems Effectiveness (CHASE Alliance). He holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.

He completed his bachelor's degree in pharmacy from Oregon State University in 1983, master's degree in administrative and economic sciences from the University of Texas in 1986 and PhD in health economics and policy from the University of California-Berkeley in 1991.

Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.

Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.

Research Interests:
Technology assessment; medical decision making; economic evaluation of pharmaceuticals, particularly in the areas of respiratory disorders, organ transplantation, HIV/AIDS, mental health and clinical decision making

SciVal Experts Profile

Contact Information

email:   sdsull@uw.edu

office:   H-375, Health Sciences Building

address:
1959 NE Pacific Street
Seattle, WA 98195-7630

campus box:   357630
voice:   206-685-8153
fax:   206-543-3835

Education

PhD   University of California (Berkeley), 1992   (Health Economics)
MS   University of Texas (Austin), 1986   (Pharmacy)
BS   Oregon State University, 1983   (Pharmacy)

Recent Publications



Seal B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases. Appl Health Econ Health Policy. 2014 Jul 9. [Epub ahead of print]  PMID: 25005491


Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, Bauer Z, Bresnahan BW, Avins AL, Nedeljkovic SS, Nerenz DR, Standaert C, Kessler L, Akuthota V, Annaswamy T, Chen A, Diehn F, Firtch W, Gerges FJ, Gilligan C, Goldberg H, Kennedy DJ, Mandel S, Tyburski M, Sanders W, Sibell D, Smuck M, Wasan A, Won L, Jarvik JG. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014 Jul 3;371(1):11-21. doi: 10.1056/NEJMoa1313265.  PMID: 24988555


Carlson JJ, Gries KS, Yeung K, Sullivan SD, Garrison LP Jr. Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers. Appl Health Econ Health Policy. 2014 Jun;12(3):231-8. doi: 10.1007/s40258-014-0093-x.  PMID: 24664994


Hansen RN, Ramsey SD, Lalla D, Masaquel A, Kamath T, Brammer M, Hurvitz SA, Sullivan SD. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens. Springerplus. 2014 May 21;3:259. doi: 10.1186/2193-1801-3-259. eCollection 2014.  PMID: 24926422    PMCID: PMC4047276


Rundell SD, Bresnahan BW, Heagerty PJ, Comstock BA, Friedly JL, Jarvik JG, Sullivan SD. Mapping a Patient-Reported Functional Outcome Measure to a Utility Measure for Comparative Effectiveness and Economic Evaluations in Older Adults with Low Back Pain. Med Decis Making. 2014 May 14. pii: 0272989X14533995. [Epub ahead of print]  PMID: 24829274


view books/publications in WorldCat

Dissertation, Thesis & Capstone Committees (recent HSERV graduates)

2012
Chair, thesis committee for Junho Jang
Cost and health status outcome among adult asthma patients: MEPS 2000-2009

External Funding (sampling of recent awards from UW SAGE data)

ARRA UW Centers for Comparative and Health Systems Effectiveness Training Program
Agency for Healthcare Research and Quality (AHRQ)
PI:   Sullivan           Dates:    10/1/2010 - 9/30/2013

Links

Pharmaceutical Outcomes Research and Policy Program

Featured